| Issuer | % of Class | Filed |
|---|---|---|
|
Tvardi Therapeutics, Inc.
13G/A
Amendment 2
TVRD · 140755307
|
4.5% |
2/17/2026
Event 12/31/2025
|
|
Tvardi Therapeutics, Inc.
13G/A
Amendment 1
CARA · 140755208
|
6.7% |
11/14/2025
Event 9/30/2025
|
|
Tvardi Therapeutics, Inc.
13G
CARA · 140755208
|
8.3% |
6/2/2025
Event 4/15/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.